Works about GLICLAZIDE

Results: 286

The effect of low and high dose empagliflozin on HbA1c and lipid profile in type 2 diabetes mellitus: A real-world data.

Published in:

Northern Clinics of Istanbul, 2020, v. 7, n. 2, p. 167, doi. 10.14744/nci.2019.22697

By:

Ozcelik, Serhat;
Celik, Mehmet;
Vural, Aski;
Aydin, Bunyamin

Publication type:

Article

Real-world evidence on the effectiveness and safety of gliclazide extended-release treatment in Indian patients with type 2 diabetes undergoing Ramadan fast: an analysis from the global DIA-RAMADAN study.

Published in:

Clinical Diabetology, 2021, v. 10, n. 6, p. 438, doi. 10.5603/DK.a2021.0041

By:

Shaikh, Shehla;
Dhand, Sunil;
Bhattacharyya, Supratik;
Modi, K.;
Moazam, S.;
Kolke, Sharat S.;
Kadam, Yogesh;
Ahmad, Syed Nazim;
Sivagnanam, T.;
Kundan, Kunal

Publication type:

Article

Real-world experience of treatment individualization based on a fixed-dose combination of gliclazide extended release+ metformin extended-release in type 2 diabetes mellitus.

Published in:

Clinical Diabetology, 2021, v. 10, n. 4, p. 337, doi. 10.5603/DK.a2021.0042

By:

Kalra, Sanjay;
Jagadeesha, Aravinda;
Khandelwal, Deepak;
Samudra, Kirti;
Gadve, Sharvil;
Bhattacharyya, Supratik

Publication type:

Article

Physicochemical characterization of gliclazide–macrogol solid dispersion and tablets based on optimized dispersion.

Published in:

Drug Development & Industrial Pharmacy, 2010, v. 36, n. 8, p. 893, doi. 10.3109/03639040903578734

By:

Khattab, Ibrahim S.;
Nada, Aly;
Zaghloul, Abdel-Azim

Publication type:

Article

Preparation and in vitro evaluation of gliclazide sustained-release matrix pellets: formulation and storage stability.

Published in:

Drug Development & Industrial Pharmacy, 2010, v. 36, n. 7, p. 814, doi. 10.3109/03639040903520967

By:

Wang, Lin;
Wang, Juan;
Lin, Xia;
Tang, Xing

Publication type:

Article

In Vitro and In Vivo Evaluation of a Novel Push-Pull Osmotic Pump with Orifices on Both Side Surfaces.

Published in:

Drug Development & Industrial Pharmacy, 2008, v. 34, n. 12, p. 1350, doi. 10.1080/10673220802122928

By:

Li, Wei;
Du, Gani;
Yang, Xinggang;
Zhang, Zhihong;
Nie, Shufang;
Peng, Bo;
Pan, Weisan

Publication type:

Article

Development of Extended Zero-Order Release Gliclazide Tablets by Central Composite Design.

Published in:

Drug Development & Industrial Pharmacy, 2008, v. 34, n. 1, p. 33, doi. 10.1080/03639040701386129

By:

Vijayalakshmi, P.;
Devi, V. Kusum;
Narendra, C.;
Srinagesh, S.

Publication type:

Article

The Influence of Hydro-Alcoholic Media on Hypromellose Matrix Systems.

Published in:

Drug Development & Industrial Pharmacy, 2007, v. 33, n. 10, p. 1125, doi. 10.1080/03639040701377862

By:

Levina, Marina;
Vuong, Hue;
Rajabi-Siahboomi, Ali R.

Publication type:

Article

Comparison of the Solubility and Dissolution Rate Between Gliclazide Solid Complex and Its Nanospheres.

Published in:

Drug Development & Industrial Pharmacy, 2007, v. 33, n. 3, p. 301, doi. 10.1080/03639040600920622

By:

Lo, Yung-Kuang;
Chen, Chiu-Ju;
Tsai, Tong-Rong;
Cham, Thau-Ming

Publication type:

Article

Preparation and In Vitro/In Vivo Evaluation of Gliclazide Loaded Eudragit Nanoparticles as a Sustained Release Carriers.

Published in:

Drug Development & Industrial Pharmacy, 2007, v. 33, n. 2, p. 101, doi. 10.1080/03639040601096695

By:

Devarajan, Padma V.;
Sonavane, Ganeshchandra S.

Publication type:

Article

Diabetic bladder dysfunction.

Published in:

British Journal of Community Nursing, 2024, v. 29, n. 5, p. 232, doi. 10.12968/bjcn.2024.29.5.232

By:

Nazarko, Linda

Publication type:

Article

A Randomized Trial of Insulin Glargine plus Oral Hypoglycemic Agents versus Continuous Subcutaneous Insulin Infusion to Treat Newly Diagnosed Type 2 Diabetes.

Published in:

Journal of Diabetes Research, 2018, p. 1, doi. 10.1155/2018/2791584

By:

Lin, Shuo;
Chen, Mu;
Chen, Wanling;
Lin, Keyi;
Mu, Panwei;
Zhu, Bilian;
Xu, Wen;
Wang, Manman;
Weng, Jianping;
Zeng, Longyi

Publication type:

Article

SPECTROPHOTOMETRIC METHOD DEVELOPMENT AND VALIDATION FOR GLICLAZIDE QUANTITATION IN TABLETS.

Published in:

Journal of Faculty of Pharmacy of Ankara University / Ankara Üniversitesi Eczacilik Fakültesi Dergisi, 2022, v. 46, n. 3, p. 920, doi. 10.33483/jfpau.1127275

By:

LELEKA, Lidiia;
VASIUK, Svitlana

Publication type:

Article

Gliclazide loaded PLGA-HPMC second generation nanocrystals for oral delivery: Design, development and in vitro performance characterization.

Published in:

Malaysian Journal of Medicine & Health Sciences, 2019, v. 15, p. 44

By:

R., Krishnamoorthy;
B. P., Panda;
N. K. H., Shivashekaregowda;
B. S., Low;
S. K., Bhattamisra

Publication type:

Article

In vitro and in vivo delivery of gliclazide loaded mPEG-PCL micelles and its kinetic release and solubility study.

Published in:

Artificial Cells, Nanomedicine & Biotechnology, 2018, v. 46, n. 8, p. 1625, doi. 10.1080/21691401.2017.1386191

By:

Danafar, Hossein;
Jaberizadeh, Hoda;
Andalib, Sina

Publication type:

Article

The role of the bile acid chenodeoxycholic acid in the targeted oral delivery of the anti-diabetic drug gliclazide, and its applications in type 1 diabetes.

Published in:

Artificial Cells, Nanomedicine & Biotechnology, 2016, v. 44, n. 6, p. 1508, doi. 10.3109/21691401.2015.1058807

By:

Mathavan, Sangeetha;
Chen-Tan, Nigel;
Arfuso, Frank;
Al-Salami, Hani

Publication type:

Article

Bioequivalence of Two Formulations of Gliclazide in a Randomized Crossover Study in Healthy Caucasian Subjects Under Fasting Conditions.

Published in:

Clinical Pharmacology in Drug Development, 2019, v. 8, n. 1, p. 16, doi. 10.1002/cpdd.445

By:

Pop, Diana Ioana;
Oroian, Monica;
Bhardwaj, Sandeep;
Marcovici, Adriana;
Khuroo, Arshad;
Kochhar, Ravi;
Vlase, Laurian

Publication type:

Article

Influence of CYP2C9 and CYP2C19 genetic polymorphisms on pharmacokinetics and pharmacodynamics of gliclazide in healthy Chinese Han volunteers.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2010, v. 35, n. 3, p. 351, doi. 10.1111/j.1365-2710.2009.01134.x

By:

Shao, H.;
Ren, X. M.;
Liu, N. F.;
Chen, G. M.;
Li, W. L.;
Zhai, Z. H.;
Wang, D. W.

Publication type:

Article

Computational studies for pre-evaluation of pharmacological profile of gut microbiota-produced gliclazide metabolites.

Published in:

Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1492284

By:

Đanić, Maja;
Pavlović, Nebojša;
Zaklan, Dragana;
Stanimirov, Bojan;
Lazarević, Slavica;
Al-Salami, Hani;
Mikov, Momir

Publication type:

Article

Glyburide use is associated with a greater likelihood of mortality or rehospitalization after acute coronary syndrome compared to gliclazide use in adults with type 2 diabetes: A cohort study.

Published in:

Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 5408, doi. 10.1111/dom.15917

By:

Long, Wentong;
Light, Peter E.;
Simpson, Scot H.

Publication type:

Article

Reflections on the sulphonylurea story: A drug class at risk of extinction or a drug class worth reviving?

Published in:

Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. 761, doi. 10.1111/dom.13596

By:

Cordiner, Ruth L. M.;
Pearson, Ewan R.

Publication type:

Article

Residual confounding in the study by van Dalem et al.

Published in:

2018

By:

Landman, Gijs W. D.;
van Hateren, Kornelis J. J.;
Kleefstra, Nanne

Publication type:

Letter to the Editor

Risk of acute coronary events associated with glyburide compared with gliclazide use in patients with type 2 diabetes: a nested case-control study.

Published in:

Diabetes, Obesity & Metabolism, 2014, v. 16, n. 1, p. 22, doi. 10.1111/dom.12173

By:

Abdelmoneim, A. S.;
Eurich, D. T.;
Gamble, J. M.;
Johnson, J. A.;
Seubert, J. M.;
Qiu, W.;
Simpson, S. H.

Publication type:

Article

Effects of St John's wort and CYP2C9 genotype on the pharmacokinetics and pharmacodynamics of gliclazide.

Published in:

2008

By:

Xu, H.;
Williams, K. M.;
Liauw, W. S.;
Murray, M.;
Day, R. O.;
McLachlan, A. J.

Publication type:

journal article

Actions of ZD0947, a novel ATP-sensitive K+ channel opener, on membrane currents in human detrusor myocytes.

Published in:

2006

By:

Aishima, M;
Tomoda, T;
Yunoki, T;
Nakano, T;
Seki, N;
Yonemitsu, Y;
Sueishi, K;
Naito, S;
Ito, Y;
Teramoto, N

Publication type:

journal article

Multiple pruritic nodules with central eschar.

Published in:

Clinical & Experimental Dermatology, 2011, v. 36, n. 3, p. 322, doi. 10.1111/j.1365-2230.2010.03911.x

By:

El-Dars, L. D.;
Intzedy, L.;
Stone, N.

Publication type:

Article

Pharmacokinetic and Drug Absorption Profiles of the Anti-Hyperglycaemic Agent Gliclazide in Oral Tissue-Targeted Microcapsules in Rats.

Published in:

Scripta Medica, 2020, v. 51, n. 1, p. 15, doi. 10.5937/scriptamed51-25521

By:

Jovic, Jelena;
Milijasevic, Boris;
Vukmirovic, Sasa;
Vasovic, Velibor;
Mikov, Momir;
Mooranian, Armin;
Al-Salami, Hani;
Golocorbin-Kon, Svetlana

Publication type:

Article

Vildagliptin has the same safety profile as a sulfonylurea on bone metabolism and bone mineral density in post-menopausal women with type 2 diabetes: a randomized controlled trial.

Published in:

Diabetology & Metabolic Syndrome, 2017, v. 9, p. 1, doi. 10.1186/s13098-017-0232-2

By:

Daher Vianna, Andre Gustavo;
de Lacerda, Claudio Silva;
Pechmann, Luciana Muniz;
Polesel, Michelle Garcia;
Marino, Emerson Cestari;
Cochenski Borba, Victoria Zeghbi;
de Carvalho Barreto, Fellype

Publication type:

Article

Attenuation of lipid peroxidation and atherogenic factors in diabetic patients treated with gliclazide and metformin.

Published in:

Journal of Research in Medical Sciences, 2018, v. 23, p. 1, doi. 10.4103/jrms.JRMS_202_17

By:

Banik, Sujan;
Hossain, Mohammad Salim;
Bhatta, Rita;
Akter, Mariyam

Publication type:

Article

Effect of Gliclazide on Motor and Cognitive Function in Haloperidol Induced Parkinson's Disease with Diabetes Mellitus as Co-Morbidity in Wistar Rats.

Published in:

Indian Journal of Pharmaceutical Sciences, 2024, v. 86, n. 5, p. 1717, doi. 10.36468/pharmaceutical-sciences.1438

By:

SHARMA, NEHA;
SAIYED, MUSARATAFRIN;
SACHDEVA, PUNAM;
SHARMA, KRUTI

Publication type:

Article

Interactions of Pearl Millet Diet on Pharmacodynamics and Pharmacokinetics of Gliclazide in Healthy Rats.

Published in:

Indian Journal of Pharmaceutical Sciences, 2024, v. 86, n. 4, p. 1505, doi. 10.36468/pharmaceutical-sciences.1415

By:

NANDABARAM, ASHA;
MAYASA, VINYAS

Publication type:

Article

Interaction of Resveratrol on the Pharmacodynamics and Pharmacokinetics of Gliclazide in Animal Models.

Published in:

Indian Journal of Pharmaceutical Sciences, 2024, v. 86, n. 3, p. 1110, doi. 10.36468/pharmaceutical-sciences.1370

By:

MATTA, S.;
KILARI, E. K.

Publication type:

Article

Experimental Design Methodology for Simultaneous Determination of Anti-Diabetic Drugs by Reverse Phase Liquid Chromatographic Method.

Published in:

Indian Journal of Pharmaceutical Sciences, 2021, v. 83, n. 3, p. 523, doi. 10.36468/pharmaceutical-sciences.801

By:

BUKKAPATNAM, V.;
ANNAPURNA, MUKTHINUTHALAPATI MATHRUSRI;
ROUTHU, K. C.

Publication type:

Article

Preparation and Crystallographic Analysis of Gliclazide Polymorphs.

Published in:

Indian Journal of Pharmaceutical Sciences, 2015, v. 77, n. 1, p. 34, doi. 10.4103/0250-474X.151595

By:

RAJAMMA, A. J.;
SATEESHA, S. B.;
NARODE, M. K.;
PRASHANTH, V. R. S. S.;
KARTHIK, A. M.

Publication type:

Article

Diabetic papillopathy: an uncommon cause of bilateral optic disc swelling.

Published in:

QJM: An International Journal of Medicine, 2012, v. 105, n. 6, p. 583, doi. 10.1093/qjmed/hcr062

By:

Wallace, I.R.;
Mulholland, D.A.;
Lindsay, J.R.

Publication type:

Article

Gliclazide disposition in overdose – a case report with pharmacokinetic modeling.

Published in:

2022

By:

Mégarbane, Bruno;
Chevillard, Lucie;
Khoudour, Nihel;
Declèves, Xavier

Publication type:

Letter

Gliclazide Removal Efficiency of Carbon‐Based Magnetic Materials: Isotherm and Kinetic Studies.

Published in:

Chemical Engineering & Technology, 2023, v. 46, n. 4, p. 635, doi. 10.1002/ceat.202200303

By:

Çavuşoğlu, Ferda Civan

Publication type:

Article

Comparative Effects of Three Sulfonylureas (Glibenclamide, Glimepiride, and Gliclazide) on Proliferation and Migration of Vascular Smooth Muscle Cells.

Published in:

Cellular Physiology & Biochemistry (Cell Physiol Biochem Press GmbH & Co. KG), 2019, v. 52, n. 1, p. 16, doi. 10.33594/000000002

By:

Rui Zhang;
Zhiwei Zou;
Xiaojun Zhou;
Xue Shen;
Zhengyuan Fan;
Tianyue Xie;
Chunmei Xu;
Lin Liao;
Jianjun Dong

Publication type:

Article

Comparison of Gliclazide Treatment with Diet Therapy on Acute Phase Protein Levels in Patients with Type 2 Diabetes.

Published in:

Turkish Journal of Medical Sciences, 2009, v. 39, n. 1, p. 73

By:

Memişoğullari, Ramazan;
Akçay, Fatih;
Coşkun, Abdurrahman;
Korkmaz, Uşur

Publication type:

Article

Diyabetli Hastalarda Gliklazid veya Metformin'in Lipid Peroksidasyonu ve Antioksidan Düzeyleri Üzerine Etkisi.

Published in:

Turkish Journal of Medical Sciences, 2008, v. 38, n. 6, p. 545

By:

Memişoğullari, Ramazan;
Türkeli, Mehmet;
Bakan, Ebubekir;
Akçay, Fatih

Publication type:

Article

Deoxycholic Acid as a Modifier of the Permeation of Gliclazide through the Blood Brain Barrier of a Rat.

Published in:

Journal of Diabetes Research, 2013, p. 1, doi. 10.1155/2013/598603

By:

Lalić-Popović, Mladena;
Vasović, Velibor;
Milijašević, Boris;
Goločorbin-Kon, Svetlana;
Al-Salami, Hani;
Mikov, Momir

Publication type:

Article

A novel mutation in the hepatocyte nuclear factor-1β gene in maturity onset diabetes of the young 5 with multiple renal cysts and pancreas hypogenesis: A case report.

Published in:

Experimental & Therapeutic Medicine, 2017, v. 14, n. 4, p. 3131, doi. 10.3892/etm.2017.4871

By:

YOU LV;
ZHUO LI;
KAN HE;
YING GAO;
XIANCHAO XIAO;
YUJIA LIU;
GUIXIA WANG

Publication type:

Article

Daily blood glucose profiles of glibenclamide and gliclazide taken once or twice daily in elderly type 2 diabetic patients.

Published in:

Geriatrics & Gerontology International, 2008, v. 8, n. 3, p. 160, doi. 10.1111/j.1447-0594.2008.00465.x

By:

Kigawa, Yoshiaki;
Oba, Kenzo;
Futami-Suda, Shoko;
Norose, Jun;
Yasuoka, Hiroko;
Suzuki, Kazunari;
Ouchi, Motoshi;
Watanabe, Kentaro;
Suzuki, Tatsuya;
Nakano, Hiroshi

Publication type:

Article

Lower occurrence of low blood glucose level in elderly type 2 diabetic patients treated with gliclazide versus glibenclamide.

Published in:

2007

By:

Oba, Kenzo;
Inuzuka, Yuki;
Yamashita-Onodera, Naoko;
Watanabe, Kentaro;
Matsumura, Noriaki;
Igari, Yoshimasa;
Suzuki, Tatsuya;
Nakano, Hiroshi

Publication type:

Letter

Identification of Prognostic Signature and Gliclazide as Candidate Drugs in Lung Adenocarcinoma.

Published in:

Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.665276

By:

Cheng, Yang;
Hou, Kezuo;
Wang, Yizhe;
Chen, Yang;
Zheng, Xueying;
Qi, Jianfei;
Yang, Bowen;
Tang, Shiying;
Han, Xu;
Shi, Dongyao;
Wang, Ximing;
Liu, Yunpeng;
Hu, Xuejun;
Che, Xiaofang

Publication type:

Article

Gliclazide Modified Release.

Published in:

Drugs, 2005, v. 65, n. 10, p. 1449, doi. 10.2165/00003495-200565100-00009

By:

Rambiritch, Virendra;
Naidoo, Poobalan

Publication type:

Article

CYP2C93 variant is associated with antidiabetes efficacy of gliclazide in Chinese type 2 diabetes patients.

Published in:

Journal of Diabetes Investigation, 2016, v. 7, n. 5, p. 764, doi. 10.1111/jdi.12486

By:

Zeng, Wotan;
Guo, Yali;
Chen, Peixian;
Liu, Zhike;
Chen, Dafang;
Han, Chunji

Publication type:

Article

An Application of Linear Mixed effect Model to Compare the Drug Treatment effect in Patients with Type 2 Diabetes.

Published in:

Indian Journal of Public Health Research & Development, 2013, v. 4, n. 1, p. 24

By:

Nath, Dilip C.;
Bhattacharjee, Atanu

Publication type:

Article

Novel Silicone-Grafted Alginate as a Drug Delivery Scaffold: Pharmaceutical Characterization of Gliclazide-Loaded Silicone-Based Composite Microcapsules.

Published in:

Pharmaceutics, 2023, v. 15, n. 2, p. 530, doi. 10.3390/pharmaceutics15020530

By:

Gedawy, Ahmed;
Luna, Giuseppe;
Martinez, Jorge;
Brown, Daniel;
Al-Salami, Hani;
Dass, Crispin R.

Publication type:

Article

Pharmacokinetics and Anti-Diabetic Studies of Gliclazide Nanosuspension.

Published in:

Pharmaceutics, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/pharmaceutics14091947

By:

Sampathi, Sunitha;
Prajapati, Shubham;
Junnuthula, Vijayabhaskarreddy;
Dyawanapelly, Sathish

Publication type:

Article